Skip to content

Self-Management Addressing Heart Disease Risk Trial

Cardiovascular Risk Factors in Veterans With Bipolar Disorder

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00499096
Acronym
SMAHRT
Enrollment
118
Registered
2007-07-11
Start date
2008-05-31
Completion date
2012-11-30
Last updated
2014-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, Cardiovascular Disease

Keywords

Chronic Illness, Disease management, Health Behaviors, Mood Disorders-Bipolar

Brief summary

The purpose of this research study is to learn whether or not people with bipolar disorder can reduce their risk of heart disease and related conditions by having a Care Manager provide self management and care management.

Detailed description

Background: Bipolar disorder is associated with significant personal and societal costs, and represents a substantial burden to the VA. Medical conditions, notably cardiovascular disease (CVD), are substantial contributors to increased morbidity and mortality in patients with bipolar disorder, in part because of behavioral and treatment factors. Despite the existence of effective medications for managing CVD-related risk factors (e.g., hypertension, hyperlipidemia, diabetes, obesity), outcomes for these conditions remain suboptimal among patients with bipolar disorder. Objectives: The immediate objective of this study is to determine whether a manual-based Chronic Care Model (CCM) intervention compared to usual VA care improves control of intermediate physiological measures that represent risk factors of CVD for veterans with bipolar disorder. We hypothesize that, within 12 months of the intervention initiation, patients receiving the CCM intervention will be more likely to demonstrate improved control of CVD-related risk factors (blood pressure, fasting cholesterol) and report improved physical health-related quality of life. Methods: This is a prospective, randomized, controlled, single-blind, single-site behavioral intervention trial of adult patients with a diagnosis of bipolar disorder receiving care in the VA Ann Arbor Healthcare System. Up to 300 subjects will be enrolled, of which 150 will be randomized to receive the intervention and 150 will receive usual VA care. All subjects will complete a baseline clinical assessment and then subsequent follow-up assessments at 3, 6, 12, and 24 months. The intervention's three core components will be implemented by a nurse Care Manager and include: 1) self-management behavioral sessions for patients addressing the reduction of CVD risk factors through symptom control and behavior change based on Social Cognitive Theory, 2) care management to promote patient behavior change and coordinate care, and 3) implementation of practice guidelines for providers on management of CVD risk factors in patients with bipolar disorder. Medical and psychiatric care, including medications, will continue to be provided by the patient's usual providers. Usual VA care will be enhanced and consist of guideline implementation and general patient education (attention control), but will not include self-management sessions or Care Manager contacts. Primary clinical outcomes include changes in cholesterol, and health-related quality of life (SF-12 physical health summary score). Linear regression models will be used to determine the effect of the intervention on each outcome. Mediators of treatment effect including symptoms and health behaviors will also be assessed.

Interventions

BEHAVIORALChronic care model for Bipolar Disorder

The behavioral intervention is based on the Chronic Care Model (CCM) where patients receive information on managing bipolar symptoms and health habits in a group self-management session (up to 6 weekly sessions). The Care Manager then follows up with patients via phone contacts for 12 months following the intervention. The providers receive information on guidelines for care.

Sponsors

US Department of Veterans Affairs
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of bipolar disorder (I, II, not otherwise specified, or schizoaffective-bipolar subtype) * Have a diagnosis or be at risk for arteriosclerotic cardiovascular disease (ASCVD). We define this as a patient having a current diagnosis of or receiving treatment for at least one of the following medical conditions: * hyperlipidemia or dyslipidemia (documented diagnosis or low-density lipoprotein \>=160, or receiving statin or other treatment) * hypertension (documented diagnosis or blood pressure of \>=140/90 on 2 occasions) * diabetes mellitus (documented diagnosis or HbA1C \>=7%, or receiving treatment) * obesity (documented diagnosis or BMI \>30), based on medical record review of current problems * current ASCVD diagnosis

Exclusion criteria

* Have unresolved substance intoxication or withdrawal, such as appearing to be intoxicated (e.g., incoherent, slurred speech), or experiencing withdrawal symptoms from substance abuse at the time of enrollment. * Are already enrolled in a mental health program with a mobile outreach component in which clinical caregivers deliver services to the patient in the community (e.g., assertive community treatment or intensive case management). These patients may be receiving similar services to those offered in the intervention. * Are unwilling or unable to provide informed consent or comply with study requirements at the time of enrollment (e.g., unable to complete forms or attend scheduled sessions due to serious illness or substantial functional limitations).

Design outcomes

Primary

MeasureTime frameDescription
Systolic and Diastolic Blood Pressure (SBP, DBP)24 months24-month systolic and diastolic blood pressure (mm/Hg): lower is better
Total Cholesterol24 monthsTotal cholesterol in mg/dl- lower is better
Physical Health-related Quality of Life Score24 monthsPhysical health-related quality of life is based on the Short Form (SF)-12 survey physical health component (PCS) score- which ranges from 0 to 50, with higher scores indicating higher quality of life

Secondary

MeasureTime frameDescription
Manic Symptoms24 monthsManic symptoms based on the Internal State Scale (range is 0-500; higher score indicates more severe symptoms)
Body Mass Index (BMI)24 monthsBody mass index (BMI) is reported in kilograms divided by meters squared (kg/m\^2) with a normal (healthy) range of 18-24, in which \>=25 is considered overweight, and \>=30 is the definition of obesity
Depressive Symptom Score24 monthsDepressive symptoms based on the Internal State Scale (Range: 0-200, higher score = more severe symptoms)
Disability Based on WHO-DAS Score24 monthsDisability based on the WHO Disability Assessment Scale (WHO-DAS); range = 0-24, higher score equals greater disability

Countries

United States

Participant flow

Participants by arm

ArmCount
Chronic Care Model for Bipolar Disorder
An intervention group of patients with bipolar disorder and 1 or more risk factor for cardiovascular disease (CVD); group will receive self-management group sessions, followed by phone contacts by the Care Manager. Chronic care model involving self-management educational sessions, care management for up to 1 year, and guideline dissemination: The behavioral intervention is based on the Chronic Care Model (CCM) where patients receive information on managing bipolar symptoms and health habits in a group self-management session (up to 6 weekly sessions). The Care Manager then follows up with patients via phone contacts for 12 months following the intervention. The providers receive information on guidelines for care.
58
Enhanced Usual Care
A group of patients with bipolar disorder and one or more risk factors for cardiovascular disease (CVD) will be randomized to receive enhanced usual care. This group will receive usual care, plus mailings on wellness topics (attention control), and their providers will receive information on guideline concordant care.
60
Total118

Baseline characteristics

CharacteristicChronic Care Model for Bipolar DisorderEnhanced Usual CareTotal
Age, Continuous53.1 years
STANDARD_DEVIATION 10.6
52.4 years
STANDARD_DEVIATION 9.2
52.8 years
STANDARD_DEVIATION 9.9
Region of Enrollment
United States
58 participants60 participants118 participants
Sex: Female, Male
Female
10 Participants10 Participants20 Participants
Sex: Female, Male
Male
48 Participants50 Participants98 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 580 / 60
serious
Total, serious adverse events
0 / 580 / 60

Outcome results

Primary

Physical Health-related Quality of Life Score

Physical health-related quality of life is based on the Short Form (SF)-12 survey physical health component (PCS) score- which ranges from 0 to 50, with higher scores indicating higher quality of life

Time frame: 24 months

ArmMeasureValue (MEAN)Dispersion
Chronic Care Model for Bipolar DisorderPhysical Health-related Quality of Life Score36.8 units on a scaleStandard Deviation 6.6
Enhanced Usual CarePhysical Health-related Quality of Life Score35.3 units on a scaleStandard Deviation 7
Primary

Systolic and Diastolic Blood Pressure (SBP, DBP)

24-month systolic and diastolic blood pressure (mm/Hg): lower is better

Time frame: 24 months

ArmMeasureGroupValue (MEAN)Dispersion
Chronic Care Model for Bipolar DisorderSystolic and Diastolic Blood Pressure (SBP, DBP)24-month DBP in mm/Hg75.9 mm/HgStandard Deviation 10.4
Chronic Care Model for Bipolar DisorderSystolic and Diastolic Blood Pressure (SBP, DBP)24-month SBP in mm/Hg127.2 mm/HgStandard Deviation 15.4
Enhanced Usual CareSystolic and Diastolic Blood Pressure (SBP, DBP)24-month SBP in mm/Hg130.4 mm/HgStandard Deviation 13.6
Enhanced Usual CareSystolic and Diastolic Blood Pressure (SBP, DBP)24-month DBP in mm/Hg78.5 mm/HgStandard Deviation 10.3
p-value: <0.05Mixed Models Analysis
Primary

Total Cholesterol

Total cholesterol in mg/dl- lower is better

Time frame: 24 months

ArmMeasureValue (MEAN)Dispersion
Chronic Care Model for Bipolar DisorderTotal Cholesterol178.9 mg/dLStandard Deviation 45.5
Enhanced Usual CareTotal Cholesterol175.9 mg/dLStandard Deviation 42.4
Secondary

Body Mass Index (BMI)

Body mass index (BMI) is reported in kilograms divided by meters squared (kg/m\^2) with a normal (healthy) range of 18-24, in which \>=25 is considered overweight, and \>=30 is the definition of obesity

Time frame: 24 months

ArmMeasureValue (MEAN)Dispersion
Chronic Care Model for Bipolar DisorderBody Mass Index (BMI)31.3 kg/m^2Standard Deviation 5.8
Enhanced Usual CareBody Mass Index (BMI)33.4 kg/m^2Standard Deviation 6.1
Secondary

Depressive Symptom Score

Depressive symptoms based on the Internal State Scale (Range: 0-200, higher score = more severe symptoms)

Time frame: 24 months

ArmMeasureValue (MEAN)Dispersion
Chronic Care Model for Bipolar DisorderDepressive Symptom Score50.6 units on a scaleStandard Deviation 46.4
Enhanced Usual CareDepressive Symptom Score60.3 units on a scaleStandard Deviation 55.9
Secondary

Disability Based on WHO-DAS Score

Disability based on the WHO Disability Assessment Scale (WHO-DAS); range = 0-24, higher score equals greater disability

Time frame: 24 months

ArmMeasureValue (MEAN)Dispersion
Chronic Care Model for Bipolar DisorderDisability Based on WHO-DAS Score15.0 units on a scaleStandard Deviation 10.9
Enhanced Usual CareDisability Based on WHO-DAS Score16.5 units on a scaleStandard Deviation 10.7
Secondary

Manic Symptoms

Manic symptoms based on the Internal State Scale (range is 0-500; higher score indicates more severe symptoms)

Time frame: 24 months

ArmMeasureValue (MEAN)Dispersion
Chronic Care Model for Bipolar DisorderManic Symptoms148.9 units on a scaleStandard Deviation 120.9
Enhanced Usual CareManic Symptoms173.4 units on a scaleStandard Deviation 105.8

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026